Organization
Division of Cancer Medicine
10 abstracts
Abstract
Real-world immune-related adverse events in patients with early triple negative breast cancer who received pembrolizumab.Org: Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Wesleyan University, Department of Breast Medical Oncology, Division of Cancer Medicine,
Abstract
Randomized clinical trial of infliximab versus vedolizumab for immune checkpoint inhibitor related colitis.Org: The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX,
Abstract
Results of IMPACT 2, a randomized study evaluating molecular profiling and targeted agents in metastatic cancer at MD Anderson Cancer Center.Org: The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, Department of Investigational Cancer Therapeutics, Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan, Division of Cancer Medicine, Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan,
Abstract
Dose optimization of novel BRAF inhibitor FORE8394 based on PK and efficacy results.Org: Memorial Sloan Kettering Cancer Center, Sylvester Comprehensive Cancer Center, Miami, FL, HonorHealth Research Institute, MD Anderson Cancer Center, University of California Irvine,
Abstract
Molecular landscape and survival outcomes on early phase clinical trials in sporadic young onset colorectal cancer.Org: Department of Gastrointestinal Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, Houston, TX, MD Anderson Cancer Center, Department of Gastrointestinal Radiation Oncology, University of Texas MD Anderson Cancer Center,
Abstract
Perspectives about healthy eating and exercise among patients and providers at the safety-net Lyndon B. Johnson (LBJ) Hospital Oncology Clinic.Org: Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, Baylor College of Medicine, MD Anderson Cancer Center,
Abstract
IMPRESS-Norway: Improving public cancer care by implementing precision cancer medicine in Norway.Org: University of Oslo, Division of Cancer Medicine, Oslo University Hospital, Division of Cancer Medicine, Oslo, Norway, Institute of Clinical Medicine, Oslo Universitetssykehus, Oslo, Norway,
Abstract
Is the digital divide between older adults and other age groups closing? Impact of telemedicine and adherence with remote symptom monitoring in older adults compared to middle age and AYA patients with cancer.Org: Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, Houston, TX, University of Texas MD Anderson Cancer Center,
Abstract
Development of a plasma biomarker panel for gastric cancer detection based on an autoimmune response signature.Org: MD Anderson Cancer Center, University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, University of Texas at MD Anderson Cancer Center, Department of Gastrointestinal Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China,
Abstract
Breast cancer early diagnosis detection of breast cancer through education of primary healthcare providers in Côte D'Ivoire.Org: CHU Treichville, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Université Grenoble Alpes, Université Alassane Ouattara Bouaké,